Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy

A novel curcumin derivative, C210, activates the Epstein–Barr virus (EBV) lytic cycle without producing infectious virions by disrupting HSP90. This discovery opens avenues for safer EBV-positive cancer therapies.

3 Denver Botanic Gardens shows are transforming the ordinary – The Cannabist

Denver Botanic Gardens sets a fine example for its cultural peers by including space for art shows at its main headquarters on York Street. It’s

September 2, 2024

RLDatix Acquires SocialClimb: Expanding Healthcare Operations

What You Should Know: – RLDatix, a global leader in connected healthcare operations software and services, has announced its acquisition of SocialClimb, a healthcare technology

September 19, 2024

A scaffolded vaccine approach for broader influenza protection

Most people who get the seasonal influenza vaccine – which contains strains of viruses from distinct virus subtypes – mount a strong immune response to

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.